Testing Experimental Medication in Healthy Subjects
common.study.values.description
“A Study of LY3556050 in Healthy Participants”
The main purpose of this study is to learn more about the safety of LY3556050 after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3556050 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3556050 or placebo and will remain in the study for up to 31 days.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - LY3556050
Administered orally.
Drug - Placebo
Administered orally.
Drug - Iohexol
Administered IV.
Drug - Metformin
Administered orally.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study With LY3556050 in Healthy Subjects
common.study.values.clinical-trial-id
NCT04156750
participant.views.study.view.id
aM843e
